The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takatsuki, F.
Right arrow Articles by Akiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takatsuki, F.
Right arrow Articles by Akiyama, Y.

The Journal of Immunology, Vol 141, Issue 9 3072-3077, Copyright © 1988 by American Association of Immunologists

ARTICLES

Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo

F Takatsuki, A Okano, C Suzuki, R Chieda, Y Takahara, T Hirano, T Kishimoto, J Hamuro and Y Akiyama
Central Research Laboratories, Ajinomoto Co., Inc., Kawasaki, Japan.

The effects of human rIL-6/B cell stimulatory factor 2 (hrIL-6/BSF-2) from Escherichia coli on murine Ag, SRBC-specific antibody responses were examined in vitro and in vivo. HrBSF-2 was effective in augmenting the primary and the anamnestic plaque-forming cells response to SRBC in vitro. The augmentation of the primary response was apparent when B cell-enriched spleen cells (B cells) were cultured with BSF-2 in the presence of IL-2. On the other hand, hrBSF-2 alone strongly enhanced the anamnestic response in a dose-dependent manner when spleen cells from SRBC-immunized mice were used. These effects of BSF-2 were abolished completely by anti-BSF-2 antibody, but not by normal rabbit Ig. Cell depletion experiments indicated that L3T4 (CD4)+ T cells, but not Lyt-2(CD8)+ T cells, and adherent cells (macrophages) have an important role in this BSF-2-induced augmentation of the response. In addition, kinetic studies showed that hrBSF-2 acts on B cells in the anamnestic response even when added relatively late in the culture. Finally, it was determined whether BSF-2 also could be active in modulating antibody responses in vivo. BSF-2 was shown to enhance the primary and secondary antibody responses in mice. The most apparent effect of BSF-2 was observed in the secondary response.


This article has been cited by other articles:


Home page
 GutHome page
B Xu, U Broome, B-G Ericzon, and S Sumitran-Holgersson
High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6
Gut, July 1, 2002; 51(1): 120 - 127.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. N. Boyaka, M. Marinaro, R. J. Jackson, S. Menon, H. Kiyono, E. Jirillo, and J. R. McGhee
IL-12 Is an Effective Adjuvant for Induction of Mucosal Immunity
J. Immunol., January 1, 1999; 162(1): 122 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Kumanogoh, S. Marukawa, T. Kumanogoh, H. Hirota, K. Yoshida, I.-S. Lee, T. Yasui, K. Yoshida, T. Taga, and T. Kishimoto
Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130
PNAS, March 18, 1997; 94(6): 2478 - 2482.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. Kanda, J. E. Wilson McManus, R. Nagai, S. Imai, T. Suzuki, D. Yang, B. M. McManus, and I. Kobayashi
Modification of Viral Myocarditis in Mice by Interleukin-6
Circ. Res., May 1, 1996; 78(5): 848 - 856.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.